BR112013030341A2 - inibidores de glutaminil ciclase radiomarcados - Google Patents
inibidores de glutaminil ciclase radiomarcadosInfo
- Publication number
- BR112013030341A2 BR112013030341A2 BR112013030341A BR112013030341A BR112013030341A2 BR 112013030341 A2 BR112013030341 A2 BR 112013030341A2 BR 112013030341 A BR112013030341 A BR 112013030341A BR 112013030341 A BR112013030341 A BR 112013030341A BR 112013030341 A2 BR112013030341 A2 BR 112013030341A2
- Authority
- BR
- Brazil
- Prior art keywords
- glutaminyl cyclase
- cyclase inhibitors
- radiolabeled
- radiolabeled glutaminyl
- inhibitors
- Prior art date
Links
- 102000003642 glutaminyl-peptide cyclotransferase Human genes 0.000 title 1
- 108010081484 glutaminyl-peptide cyclotransferase Proteins 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0453—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/10—Organic compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
- C07B59/002—Heterocyclic compounds
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Optics & Photonics (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161490654P | 2011-05-27 | 2011-05-27 | |
| PCT/EP2012/059649 WO2012163773A1 (en) | 2011-05-27 | 2012-05-24 | Radiolabelled glutaminyl cyclase inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112013030341A2 true BR112013030341A2 (pt) | 2016-11-29 |
Family
ID=46149465
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112013030341A BR112013030341A2 (pt) | 2011-05-27 | 2012-05-24 | inibidores de glutaminil ciclase radiomarcados |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US8945510B2 (https=) |
| EP (1) | EP2714098A1 (https=) |
| JP (1) | JP2014515364A (https=) |
| KR (1) | KR20140028076A (https=) |
| CN (1) | CN103561776B (https=) |
| AU (1) | AU2012264951A1 (https=) |
| BR (1) | BR112013030341A2 (https=) |
| CA (1) | CA2835014A1 (https=) |
| EA (1) | EA028533B1 (https=) |
| IL (1) | IL229187A (https=) |
| MX (1) | MX2013013946A (https=) |
| SG (2) | SG10201604304RA (https=) |
| WO (1) | WO2012163773A1 (https=) |
| ZA (1) | ZA201308329B (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9512115B2 (en) | 2013-03-15 | 2016-12-06 | Probiodrug Ag | Inhibitors |
| CN104230778B (zh) * | 2014-07-14 | 2017-01-04 | 大连大学 | β-烃氧酰基-γ-烃基-N-烃基-γ-丁内酰胺的合成方法 |
| HRP20220522T1 (hr) | 2014-08-04 | 2022-06-10 | Nuevolution A/S | Proizvoljno kondenzirani heterociklil-supstituirani derivati pirimidina koji su korisni za liječenje upalnih, metaboličkih, onkoloških i autoimunih bolesti |
| US10513515B2 (en) | 2017-08-25 | 2019-12-24 | Biotheryx, Inc. | Ether compounds and uses thereof |
| AU2019309894A1 (en) | 2018-07-27 | 2021-01-28 | Biotheryx, Inc. | Bifunctional compounds as CDK modulators |
| KR102230832B1 (ko) * | 2019-06-17 | 2021-03-24 | (주) 메디프론디비티 | N-치환된 티오우레아 또는 우레아 유도체 및 이를 유효성분으로 함유하는 글루타미닐 사이클레이즈 활성 관련 질환의 예방 또는 치료용 약학적 조성물 |
| US11685727B2 (en) | 2019-12-20 | 2023-06-27 | Nuevolution A/S | Compounds active towards nuclear receptors |
| MX2022007265A (es) | 2019-12-20 | 2022-09-09 | Nuevolution As | Compuestos activos frente a receptores nucleares. |
| CA3174176A1 (en) | 2020-03-31 | 2021-10-07 | Sanne Schroder Glad | Compounds active towards nuclear receptors |
| EP4126874A1 (en) | 2020-03-31 | 2023-02-08 | Nuevolution A/S | Compounds active towards nuclear receptors |
| US11897930B2 (en) | 2020-04-28 | 2024-02-13 | Anwita Biosciences, Inc. | Interleukin-2 polypeptides and fusion proteins thereof, and their pharmaceutical compositions and therapeutic applications |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1250834B (https=) | 1963-01-09 | |||
| US5304367A (en) * | 1990-11-16 | 1994-04-19 | New York University | In vivo brain imaging agent and method for diagnosis of psychiatric disorders |
| US7732162B2 (en) * | 2003-05-05 | 2010-06-08 | Probiodrug Ag | Inhibitors of glutaminyl cyclase for treating neurodegenerative diseases |
| US7304086B2 (en) * | 2004-02-05 | 2007-12-04 | Probiodrug Ag | Inhibitors of glutaminyl cyclase |
| WO2007124345A2 (en) | 2006-04-21 | 2007-11-01 | The Government Of The United States, As Represented By The Secretary Of Health And Human Services | Beta-amyloid pet imaging agents |
| EP2089383B1 (en) * | 2006-11-09 | 2015-09-16 | Probiodrug AG | 3-hydr0xy-1,5-dihydr0-pyrr0l-2-one derivatives as inhibitors of glutaminyl cyclase for the treatment of ulcer, cancer and other diseases |
| CN103983787A (zh) * | 2008-07-31 | 2014-08-13 | 前体生物药物股份公司 | 作为神经退行性疾病诊断/预后指示物的谷氨酰胺酰环化酶 |
| AU2009289238B2 (en) * | 2008-09-04 | 2014-09-04 | Vivoryon Therapeutics N.V. | Novel inhibitors |
| CN103739605B (zh) | 2009-03-23 | 2016-08-17 | 伊莱利利公司 | 用于检测神经障碍的显像剂 |
| JP5934645B2 (ja) * | 2009-09-11 | 2016-06-15 | プロビオドルグ エージー | グルタミニルシクラーゼ阻害剤としてのヘテロ環式誘導体 |
| JP5688745B2 (ja) * | 2010-03-10 | 2015-03-25 | プロビオドルグ エージー | グルタミニルシクラーゼ（ｑｃ、ｅｃ２．３．２．５）の複素環阻害剤 |
-
2012
- 2012-05-24 US US13/479,826 patent/US8945510B2/en not_active Expired - Fee Related
- 2012-05-24 WO PCT/EP2012/059649 patent/WO2012163773A1/en not_active Ceased
- 2012-05-24 EP EP12723476.3A patent/EP2714098A1/en not_active Withdrawn
- 2012-05-24 CA CA 2835014 patent/CA2835014A1/en not_active Abandoned
- 2012-05-24 AU AU2012264951A patent/AU2012264951A1/en not_active Abandoned
- 2012-05-24 EA EA201301334A patent/EA028533B1/ru not_active IP Right Cessation
- 2012-05-24 BR BR112013030341A patent/BR112013030341A2/pt not_active IP Right Cessation
- 2012-05-24 SG SG10201604304RA patent/SG10201604304RA/en unknown
- 2012-05-24 MX MX2013013946A patent/MX2013013946A/es unknown
- 2012-05-24 KR KR20137033449A patent/KR20140028076A/ko not_active Withdrawn
- 2012-05-24 CN CN201280025603.6A patent/CN103561776B/zh not_active Expired - Fee Related
- 2012-05-24 JP JP2014511862A patent/JP2014515364A/ja active Pending
- 2012-05-24 SG SG2013081567A patent/SG194770A1/en unknown
-
2013
- 2013-10-31 IL IL229187A patent/IL229187A/en not_active IP Right Cessation
- 2013-11-06 ZA ZA2013/08329A patent/ZA201308329B/en unknown
-
2014
- 2014-12-15 US US14/570,350 patent/US9610368B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US20120301398A1 (en) | 2012-11-29 |
| EA028533B1 (ru) | 2017-11-30 |
| NZ617581A (en) | 2016-03-31 |
| JP2014515364A (ja) | 2014-06-30 |
| CA2835014A1 (en) | 2012-12-06 |
| AU2012264951A1 (en) | 2013-12-12 |
| ZA201308329B (en) | 2015-02-25 |
| US9610368B2 (en) | 2017-04-04 |
| MX2013013946A (es) | 2014-01-31 |
| WO2012163773A1 (en) | 2012-12-06 |
| EA201301334A1 (ru) | 2014-05-30 |
| KR20140028076A (ko) | 2014-03-07 |
| IL229187A (en) | 2017-04-30 |
| US8945510B2 (en) | 2015-02-03 |
| IL229187A0 (en) | 2013-12-31 |
| US20150104389A1 (en) | 2015-04-16 |
| SG10201604304RA (en) | 2016-07-28 |
| EP2714098A1 (en) | 2014-04-09 |
| SG194770A1 (en) | 2013-12-30 |
| CN103561776B (zh) | 2016-08-31 |
| CN103561776A (zh) | 2014-02-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO6801749A2 (es) | Inhibidores de glucosilceramida sintasa | |
| BR112013030341A2 (pt) | inibidores de glutaminil ciclase radiomarcados | |
| CR20120576A (es) | Inhibidores de pirazolil quinazolina cinasa | |
| BR112014002359A2 (pt) | composições de solda | |
| LT2742151T (lt) | Polimerazės kompozicija | |
| PT2684880T (pt) | Derivado de dispiropirrolidina | |
| EP2710007A4 (en) | Kinase inhibitors | |
| BR112013029474A2 (pt) | ferramenta multi-abrasiva | |
| BR112013022112A2 (pt) | composição | |
| CO6970602A2 (es) | Inhibidores de quinasa | |
| CO6890099A2 (es) | Nuevos derivados dihidroquinolina-2-ona | |
| BR112013022102A2 (pt) | composição | |
| DK2686017T3 (da) | Oftalmisk sammensætning | |
| BR112014004395A2 (pt) | composição | |
| CU24164B1 (es) | Inhibidores sustituidos de acetil-coa carboxilasa | |
| EP2783709A4 (en) | SUBMUCOSIVE DAMPER | |
| DK2691685T3 (da) | Rørledningsredskab | |
| EP2602037A4 (en) | Coated tool | |
| BR112013033808A2 (pt) | composição | |
| DK2564995T3 (da) | Værktøj | |
| EP2730619A4 (en) | COMPOSITION | |
| BR112013014148A2 (pt) | inibidores de corrosão | |
| CO6960557A2 (es) | Derivados de 2-yodo-imidazol | |
| PT2739276T (pt) | Composição antisséptica | |
| BR112014007030A2 (pt) | composição |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 6A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |